Tenderwize
Wróć do wyszukiwania

Open-house rebate agreements for Tacrolimus

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 645 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tacrolimus, ATC L04AD02

62/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

62 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Non-exclusive rebate agreements for pharmaceutical products containing Tacrolimus, ATC L04AD02.
  • Open-house model with identical contract terms for all eligible pharmaceutical companies.
Pokaż pełne podsumowanie

This is an open-house pharmaceutical supply arrangement for Tacrolimus (CPV 33600000) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated eligibility condition can conclude identical, non-negotiable, non-exclusive rebate agreements. The contract period runs from 2026-08-01 to 2028-07-31, with contract entry possible at any time until 2028-06-03. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German-language requirements apply, and non-German documents must be submitted with a German translation.

Ryzyka

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • The contract and the annex 'Determination of the contract products' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability must be submitted.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreements for Tacrolimus

Open-house supply arrangement for Tacrolimus, ATC L04AD02, for pharmaceutical companies. The lot is described as a non-exclusive rebate agreement model with identical, non-individually negotiable contract terms. Performance is in Germany (DE212).

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Jul 2026 - Jul 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jun 03, 2028

Szczegóły zamówienia

Data publikacji
14 Jun 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
409342-2026

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30